|1.||Fridman, Rafael: 4 articles (07/2011 - 07/2007)|
|2.||Sorsa, Timo: 3 articles (12/2014 - 04/2006)|
|3.||Zhao, Huiren: 3 articles (12/2008 - 07/2007)|
|4.||Sun, Qing: 3 articles (12/2008 - 07/2007)|
|5.||Sohail, Anjum: 3 articles (12/2008 - 07/2007)|
|6.||Hagström, Jaana: 2 articles (12/2014 - 02/2008)|
|7.||Cho, Hyojin: 2 articles (08/2010 - 08/2008)|
|8.||Eliceiri, George L: 2 articles (08/2010 - 08/2008)|
|9.||Radichev, Ilian A: 2 articles (05/2010 - 10/2009)|
|10.||Remacle, Albert G: 2 articles (05/2010 - 10/2009)|
12/01/2014 - "Immunohistochemistry revealed MMP-7 and MMP-25 expression in 90% (n = 63 of 70) and 90% (n = 64 of 71) of the tumors, respectively. "
04/13/2012 - "The neutrophil-specific protease membrane-type 6 matrix metalloproteinase (MT6-MMP)/MMP-25/leukolysin is implicated in multiple sclerosis and cancer yet remains poorly characterized. "
05/21/2010 - "Because MT6-MMP has been suggested to play a role in disease, including cancer and autoimmune multiple sclerosis, the identity of its physiologically relevant cleavage targets remains to be determined."
07/27/2007 - "Here we found a marked increase in MT6-MMP expression within in situ dysplasia and invasive cancer in 61 samples of human colon cancer. "
07/27/2007 - "MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties."
|2.||Breast Neoplasms (Breast Cancer)
08/01/2008 - "Using reverse transcription real-time PCR, we detected gene expression of 26 matrix metalloproteinases (MMPs) in MDA-MB-231 breast cancer cells, including those of MMP-12, MMP-16 variant 2, MMP-19, MMP-20, MMP-21, MMP-23, MMP-24, MMP-25, MMP-25 variant 2, MMP-L1, MMP-26, MMP-27, and MMP-28, in contrast to the 13 MMPs detected until now in these cells. "
08/01/2010 - "The goals of the present study were to test whether the preceding observations occur only in breast cancer cells and, if not, whether the same downregulatory and upregulatory signaling pathways are active in cells of other human cancers, focusing on activator protein-2alpha, E-cadherin, fibulin1D, interleukin 4, p16(INK4alpha), p53, PTEN, and RKIP, and on MMP1, MMP2, MMP7, MMP13, MMP14, MMP16, MMP19, and MMP25. "
|4.||Aggressive Periodontitis (Periodontosis)
|5.||Periodontal Diseases (Periodontal Disease)
04/01/2006 - "The present study demonstrated the presence of soluble or shed forms of MMP-25 and MMP-26 in GCF of patients with different periodontal diseases. "
04/01/2006 - "Our study aimed to examine the levels, molecular forms, and degrees of activation of MMP-25 and MMP-26 in gingival crevicular fluid (GCF) from patients with different periodontal diseases. "
04/01/2006 - "Increased levels and activation of MMP-25 and MMP-26 in GCF are associated with an enhanced severity of periodontal inflammation, suggesting that these novel MMPs can participate in the progression of periodontal diseases. "
|1.||Interleukin-4 (Interleukin 4)
|3.||Messenger RNA (mRNA)
|6.||matrix metalloproteinase 25
|8.||Interleukin-1 Type II Receptors
|9.||Glutathione S-Transferase pi